Cancer cells in bone marrow produced vascular endothelial growth factor (VEGF) but its angiogenic effects were canceled by thrombospondin 1, which was released by endothelial cells in niches, thereby resulting in decreased tumor formation [46]. The gene discussed is THBS1; the disease is cancer.